(Q68307894)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1677097%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Pulsed high-dose cefotaxime therapy in refractory Lyme borreliosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1677097%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

1 reference

D. Hassler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1677097

26 October 2022

K. Riedel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1677097

26 October 2022

J. Zorn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1677097

26 October 2022

V. Preac-Mursic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1677097

26 October 2022

language of work or name

English

0 references

publication date

1 July 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1677097%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

20 July 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1677097

full work available at URL

26 October 2022

https://api.elsevier.com/content/article/PII:014067369190188U?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90188-U

https://api.elsevier.com/content/article/PII:014067369190188U?httpAccept=text/plain

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90188-U

26 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1677097%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1677097%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

8760

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1677097%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1677097%20AND%20SRC:MED&resulttype=core&format=json

Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin

23 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90188-U

Cefotaxime versus penicillin in the late stage of Lyme disease--prospective, randomized therapeutic study.

26 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90188-U

Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis

26 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)90188-U

26 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1677097%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference